Drug Channels Institute (DCI) is a leading provider of specialized management education and computer-based training for and about the pharmaceutical industry. >


DCI delivers educational solutions for clients that enhance the business acumen of employees, from senior executives to field reps to internal operations. State-of-the-art instructional design, coupled with extensive industry knowledge, allows DCI to build rigorous programs with accurate, fact-based content reflecting the latest developments. Even better, we deliver the material in an engaging, accessible manner using turn-key technology solutions. View a sample of our modules

View Sample

Industry Reports

The 2017 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

This completely updated, revised, and expanded analysis of the $360+ billion U.S. pharmacy industry thoroughly dissects its interactions with the U.S. healthcare system. more >

The 2016-17 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of $400 billion U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

Building the Infrastructure for Outcomes-based Contracts

Today’s guest post comes from Scott Pribyl, CEO of mRx Ventures.Scott discusses outcomes-based contracts for specialty drugs. He describes the challenges associated with data collection and collaboration among all the more >

Drug Channels News Roundup, April 2017: Teva, Diplomat Pharmacy, Oncology Practices, and Starbucks

Time for our monthly roundup of news stories that highlight key trends for U.S. drug channels. In this issue, get your claws into the following:Teva launches an Advair competitor with more >